<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">37291679</PMID><DateCompleted><Year>2023</Year><Month>06</Month><Day>13</Day></DateCompleted><DateRevised><Year>2023</Year><Month>10</Month><Day>25</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">2523-3106</ISSN><JournalIssue CitedMedium="Internet"><Volume>63</Volume><Issue>1</Issue><PubDate><Year>2023</Year><Month>Jun</Month><Day>08</Day></PubDate></JournalIssue><Title>Advances in rheumatology (London, England)</Title><ISOAbbreviation>Adv Rheumatol</ISOAbbreviation></Journal><ArticleTitle>Post-acute COVID-19 in three doses vaccinated autoimmune rheumatic diseases patients: frequency and pattern of this condition.</ArticleTitle><Pagination><StartPage>26</StartPage><MedlinePgn>26</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">26</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1186/s42358-023-00309-z</ELocationID><Abstract><AbstractText Label="BACKGROUND">Data on post-acute COVID-19 in autoimmune rheumatic diseases (ARD) are scarce, focusing on a single disease, with variable definitions of this condition and time of vaccination. The aim of this study was to evaluate the frequency and pattern of post-acute COVID-19 in vaccinated patients with ARD using established diagnosis criteria.</AbstractText><AbstractText Label="METHODS">Retrospective evaluation of a prospective cohort of 108 ARD patients and 32 non-ARD controls, diagnosed with SARS-CoV-2 infection (RT-PCR/antigen test) after the third dose of the CoronaVac vaccine. Post-acute COVID-19 (&#x2265;&#x2009;4&#xa0;weeks and &gt;&#x2009;12&#xa0;weeks of SARS-CoV-2 symptoms) were registered according to the established international criteria.</AbstractText><AbstractText Label="RESULTS">ARD patients and non-ARD controls, balanced for age and sex, had high and comparable frequencies of &#x2265;&#x2009;4&#xa0;weeks post-acute COVID-19 (58.3% vs. 53.1%, p&#x2009;=&#x2009;0.6854) and &gt;&#x2009;12&#xa0;weeks post-acute COVID-19 (39.8% vs. 46.9%, p&#x2009;=&#x2009;0.5419). Regarding &#x2265;&#x2009;4&#xa0;weeks post-acute COVID-19, frequencies of &#x2265;&#x2009;3 symptoms were similar in ARD and non-ARD controls (54% vs. 41.2%, p&#x2009;=&#x2009;0.7886), and this was also similar in &gt;&#x2009;12&#xa0;weeks post-acute COVID-19 (68.3% vs. 88.2%, p&#x2009;=&#x2009;0.1322). Further analysis of the risk factors for &#x2265;&#x2009;4&#xa0;weeks post-acute COVID-19 in ARD patients revealed that age, sex, clinical severity of COVID-19, reinfection, and autoimmune diseases were not associated with this condition (p&#x2009;&gt;&#x2009;0.05). The clinical manifestations of post-acute COVID-19 were similar in both groups (p&#x2009;&gt;&#x2009;0.05), with fatigue and memory loss being the most frequent manifestations.</AbstractText><AbstractText Label="CONCLUSION">We provide novel data demonstrating that immune/inflammatory ARD disturbances after third dose vaccination do not seem to be a major determinant of post-acute COVID-19 since its pattern is very similar to that of the general population. Clinical Trials platform (NCT04754698).</AbstractText><CopyrightInformation>&#xa9; 2023. The Author(s).</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y" EqualContrib="Y"><LastName>Silva</LastName><ForeName>Clovis Artur</ForeName><Initials>CA</Initials><AffiliationInfo><Affiliation>Rheumatology Division, Hospital das Clinicas HCFMUSP, Faculdade de Medicina, Universidade de Sao Paulo, Av. Dr. Arnaldo, 455, sala 3190 - Cerqueira C&#xe9;sar, S&#xe3;o Paulo, SP, 01246-903, Brazil.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Pediatric Rheumatology Unit, Instituto da Crian&#xe7;a e do Adolescente, Hospital das Clinicas HCFMUSP, Faculdade de Medicina, Universidade de Sao Paulo, S&#xe3;o Paulo, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y" EqualContrib="Y"><LastName>de Vinci Kanda Kupa</LastName><ForeName>Leonard</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Rheumatology Division, Hospital das Clinicas HCFMUSP, Faculdade de Medicina, Universidade de Sao Paulo, Av. Dr. Arnaldo, 455, sala 3190 - Cerqueira C&#xe9;sar, S&#xe3;o Paulo, SP, 01246-903, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Medeiros-Ribeiro</LastName><ForeName>Ana Cristina</ForeName><Initials>AC</Initials><AffiliationInfo><Affiliation>Rheumatology Division, Hospital das Clinicas HCFMUSP, Faculdade de Medicina, Universidade de Sao Paulo, Av. Dr. Arnaldo, 455, sala 3190 - Cerqueira C&#xe9;sar, S&#xe3;o Paulo, SP, 01246-903, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pasoto</LastName><ForeName>Sandra Gofinet</ForeName><Initials>SG</Initials><AffiliationInfo><Affiliation>Rheumatology Division, Hospital das Clinicas HCFMUSP, Faculdade de Medicina, Universidade de Sao Paulo, Av. Dr. Arnaldo, 455, sala 3190 - Cerqueira C&#xe9;sar, S&#xe3;o Paulo, SP, 01246-903, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Saad</LastName><ForeName>Carla Gon&#xe7;alves Schahin</ForeName><Initials>CGS</Initials><AffiliationInfo><Affiliation>Rheumatology Division, Hospital das Clinicas HCFMUSP, Faculdade de Medicina, Universidade de Sao Paulo, Av. Dr. Arnaldo, 455, sala 3190 - Cerqueira C&#xe9;sar, S&#xe3;o Paulo, SP, 01246-903, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yuki</LastName><ForeName>Emily Figueiredo Neves</ForeName><Initials>EFN</Initials><AffiliationInfo><Affiliation>Rheumatology Division, Hospital das Clinicas HCFMUSP, Faculdade de Medicina, Universidade de Sao Paulo, Av. Dr. Arnaldo, 455, sala 3190 - Cerqueira C&#xe9;sar, S&#xe3;o Paulo, SP, 01246-903, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Landim</LastName><ForeName>Joaquim Ivo Vasques Dantas</ForeName><Initials>JIVD</Initials><AffiliationInfo><Affiliation>Rheumatology Division, Hospital das Clinicas HCFMUSP, Faculdade de Medicina, Universidade de Sao Paulo, Av. Dr. Arnaldo, 455, sala 3190 - Cerqueira C&#xe9;sar, S&#xe3;o Paulo, SP, 01246-903, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>L&#xe9;da</LastName><ForeName>Victor Hugo Ferreira E</ForeName><Initials>VHFE</Initials><AffiliationInfo><Affiliation>Rheumatology Division, Hospital das Clinicas HCFMUSP, Faculdade de Medicina, Universidade de Sao Paulo, Av. Dr. Arnaldo, 455, sala 3190 - Cerqueira C&#xe9;sar, S&#xe3;o Paulo, SP, 01246-903, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>de Camargo Correia</LastName><ForeName>Luisa Sacchi</ForeName><Initials>LS</Initials><AffiliationInfo><Affiliation>Rheumatology Division, Hospital das Clinicas HCFMUSP, Faculdade de Medicina, Universidade de Sao Paulo, Av. Dr. Arnaldo, 455, sala 3190 - Cerqueira C&#xe9;sar, S&#xe3;o Paulo, SP, 01246-903, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sartori</LastName><ForeName>Artur Fonseca</ForeName><Initials>AF</Initials><AffiliationInfo><Affiliation>Rheumatology Division, Hospital das Clinicas HCFMUSP, Faculdade de Medicina, Universidade de Sao Paulo, Av. Dr. Arnaldo, 455, sala 3190 - Cerqueira C&#xe9;sar, S&#xe3;o Paulo, SP, 01246-903, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Martins</LastName><ForeName>Carolina Campagnoli Machado Freire</ForeName><Initials>CCMF</Initials><AffiliationInfo><Affiliation>Rheumatology Division, Hospital das Clinicas HCFMUSP, Faculdade de Medicina, Universidade de Sao Paulo, Av. Dr. Arnaldo, 455, sala 3190 - Cerqueira C&#xe9;sar, S&#xe3;o Paulo, SP, 01246-903, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ribeiro</LastName><ForeName>Carolina Torres</ForeName><Initials>CT</Initials><AffiliationInfo><Affiliation>Rheumatology Division, Hospital das Clinicas HCFMUSP, Faculdade de Medicina, Universidade de Sao Paulo, Av. Dr. Arnaldo, 455, sala 3190 - Cerqueira C&#xe9;sar, S&#xe3;o Paulo, SP, 01246-903, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Waridel</LastName><ForeName>Filipe</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Rheumatology Division, Hospital das Clinicas HCFMUSP, Faculdade de Medicina, Universidade de Sao Paulo, Av. Dr. Arnaldo, 455, sala 3190 - Cerqueira C&#xe9;sar, S&#xe3;o Paulo, SP, 01246-903, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>de Oliveira Martins</LastName><ForeName>Victor Adriano</ForeName><Initials>VA</Initials><AffiliationInfo><Affiliation>Rheumatology Division, Hospital das Clinicas HCFMUSP, Faculdade de Medicina, Universidade de Sao Paulo, Av. Dr. Arnaldo, 455, sala 3190 - Cerqueira C&#xe9;sar, S&#xe3;o Paulo, SP, 01246-903, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Shinjo</LastName><ForeName>Samuel Katsuyuki</ForeName><Initials>SK</Initials><AffiliationInfo><Affiliation>Rheumatology Division, Hospital das Clinicas HCFMUSP, Faculdade de Medicina, Universidade de Sao Paulo, Av. Dr. Arnaldo, 455, sala 3190 - Cerqueira C&#xe9;sar, S&#xe3;o Paulo, SP, 01246-903, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Andrade</LastName><ForeName>Danieli Castro Oliveira</ForeName><Initials>DCO</Initials><AffiliationInfo><Affiliation>Rheumatology Division, Hospital das Clinicas HCFMUSP, Faculdade de Medicina, Universidade de Sao Paulo, Av. Dr. Arnaldo, 455, sala 3190 - Cerqueira C&#xe9;sar, S&#xe3;o Paulo, SP, 01246-903, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sampaio-Barros</LastName><ForeName>Percival Degrava</ForeName><Initials>PD</Initials><AffiliationInfo><Affiliation>Rheumatology Division, Hospital das Clinicas HCFMUSP, Faculdade de Medicina, Universidade de Sao Paulo, Av. Dr. Arnaldo, 455, sala 3190 - Cerqueira C&#xe9;sar, S&#xe3;o Paulo, SP, 01246-903, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Neto</LastName><ForeName>Eduardo Ferreira Borba</ForeName><Initials>EFB</Initials><AffiliationInfo><Affiliation>Rheumatology Division, Hospital das Clinicas HCFMUSP, Faculdade de Medicina, Universidade de Sao Paulo, Av. Dr. Arnaldo, 455, sala 3190 - Cerqueira C&#xe9;sar, S&#xe3;o Paulo, SP, 01246-903, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Aikawa</LastName><ForeName>Nadia Emi</ForeName><Initials>NE</Initials><AffiliationInfo><Affiliation>Rheumatology Division, Hospital das Clinicas HCFMUSP, Faculdade de Medicina, Universidade de Sao Paulo, Av. Dr. Arnaldo, 455, sala 3190 - Cerqueira C&#xe9;sar, S&#xe3;o Paulo, SP, 01246-903, Brazil.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Pediatric Rheumatology Unit, Instituto da Crian&#xe7;a e do Adolescente, Hospital das Clinicas HCFMUSP, Faculdade de Medicina, Universidade de Sao Paulo, S&#xe3;o Paulo, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bonfa</LastName><ForeName>Eloisa</ForeName><Initials>E</Initials><Identifier Source="ORCID">0000-0002-0520-4681</Identifier><AffiliationInfo><Affiliation>Rheumatology Division, Hospital das Clinicas HCFMUSP, Faculdade de Medicina, Universidade de Sao Paulo, Av. Dr. Arnaldo, 455, sala 3190 - Cerqueira C&#xe9;sar, S&#xe3;o Paulo, SP, 01246-903, Brazil. eloisa.bonfa@hc.fm.usp.br.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><DataBankList CompleteYN="Y"><DataBank><DataBankName>ClinicalTrials.gov</DataBankName><AccessionNumberList><AccessionNumber>NCT04754698</AccessionNumber></AccessionNumberList></DataBank></DataBankList><PublicationTypeList><PublicationType UI="D000068397">Clinical Study</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>06</Month><Day>08</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Adv Rheumatol</MedlineTA><NlmUniqueID>101734172</NlmUniqueID><ISSNLinking>2523-3106</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C000722216">sinovac COVID-19 vaccine</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001327" MajorTopicYN="Y">Autoimmune Diseases</DescriptorName><QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000517" MajorTopicYN="N">prevention &amp; control</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011446" MajorTopicYN="N">Prospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012189" MajorTopicYN="N">Retrospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012216" MajorTopicYN="Y">Rheumatic Diseases</DescriptorName><QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000086402" MajorTopicYN="N">SARS-CoV-2</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Autoimmune diseases</Keyword><Keyword MajorTopicYN="N">COVID-19</Keyword><Keyword MajorTopicYN="N">Long COVID-19</Keyword><Keyword MajorTopicYN="N">Post-COVID-19 syndrome</Keyword></KeywordList><CoiStatement>The authors declare no competing interests.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2023</Year><Month>2</Month><Day>22</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>5</Month><Day>29</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>6</Month><Day>12</Day><Hour>6</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>6</Month><Day>9</Day><Hour>1</Hour><Minute>9</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>6</Month><Day>8</Day><Hour>23</Hour><Minute>46</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2023</Year><Month>6</Month><Day>8</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">37291679</ArticleId><ArticleId IdType="pmc">PMC10248954</ArticleId><ArticleId IdType="doi">10.1186/s42358-023-00309-z</ArticleId><ArticleId IdType="pii">10.1186/s42358-023-00309-z</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Soriano JB, Murthy S, Marshall JC, Relan P, Diaz JV. A clinical case definition of post-COVID-19 condition by a Delphi consensus. Lancet Infect Dis. 2022;22:e102&#x2013;e107. doi: 10.1016/S1473-3099(21)00703-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1473-3099(21)00703-9</ArticleId><ArticleId IdType="pmc">PMC8691845</ArticleId><ArticleId IdType="pubmed">34951953</ArticleId></ArticleIdList></Reference><Reference><Citation>Nalbandian A, Sehgal K, Gupta A, Madhavan MV, McGroder C, Stevens JS, et al. Post-acute COVID-19 syndrome. Nat Med. 2021;27:601&#x2013;615. doi: 10.1038/s41591-021-01283-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-021-01283-z</ArticleId><ArticleId IdType="pmc">PMC8893149</ArticleId><ArticleId IdType="pubmed">33753937</ArticleId></ArticleIdList></Reference><Reference><Citation>Thompson EJ, Williams DM, Walker AJ, Mitchell RE, Niedzwiedz CL, Yang TC, et al. Long COVID burden and risk factors in 10 UK longitudinal studies and electronic health records. Nat Commun. 2022 doi: 10.1038/s41467-022-30836-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-022-30836-0</ArticleId><ArticleId IdType="pmc">PMC9240035</ArticleId><ArticleId IdType="pubmed">35764621</ArticleId></ArticleIdList></Reference><Reference><Citation>Whitaker M, Elliott J, Chadeau-Hyam M, Riley S, Darzi A, Cooke G, et al. Persistent COVID-19 symptoms in a community study of 606,434 people in England. Nat Commun. 2022;13(1):1&#x2013;10. doi: 10.1038/s41467-022-29521-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-022-29521-z</ArticleId><ArticleId IdType="pmc">PMC9005552</ArticleId><ArticleId IdType="pubmed">35413949</ArticleId></ArticleIdList></Reference><Reference><Citation>De Miranda DAP, Gomes SVC, Filgueiras PS, Corsini CA, Almeida NBF, Silva RA, et al. Long COVID-19 syndrome: a 14-months longitudinal study during the two first epidemic peaks in Southeast Brazil. Orig Artic Trans R Soc Trop Med Hyg. 2022;0:1&#x2013;8. doi: 10.1093/trstmh/trac030/6581500.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/trstmh/trac030/6581500</ArticleId><ArticleId IdType="pubmed">35514142</ArticleId></ArticleIdList></Reference><Reference><Citation>Conway R, Grimshaw AA, Konig MF, Putman M, Duarte-Garc&#xed;a A, Tseng LY, et al. SARS&#x2013;CoV-2 infection and COVID-19 outcomes in rheumatic diseases: a systematic literature review and meta-analysis. Arthritis Rheumatol. 2022;74:766&#x2013;775. doi: 10.1002/art.42030.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/art.42030</ArticleId><ArticleId IdType="pmc">PMC9011807</ArticleId><ArticleId IdType="pubmed">34807517</ArticleId></ArticleIdList></Reference><Reference><Citation>Brito-Zer&#xf3; P, Acar-Denizl N, Rom&#xe3;o VC, Armagan B, Seror R, Carubbi F, et al. Post-COVID-19 syndrome in patients with primary Sj&#xf6;gren&#x2019;s syndrome after acute SARS-CoV-2 infection. Clin Exp Rheumatol. 2021;39:57&#x2013;65. doi: 10.55563/clinexprheumatol/0anatx.</Citation><ArticleIdList><ArticleId IdType="doi">10.55563/clinexprheumatol/0anatx</ArticleId><ArticleId IdType="pubmed">34874821</ArticleId></ArticleIdList></Reference><Reference><Citation>Rivera J, Rodr&#xed;guez T, Pallar&#xe9;s M, Castrej&#xf3;n I, Gonz&#xe1;lez T, Vallejo-Slocker L, et al. Protocol for a multicenter randomized controlled trial comparing a non-opioid prescription to the standard of care for pain control following arthroscopic knee and shoulder surgery. BMC Musculoskelet Disord. 2021 doi: 10.1186/s12891-022-05436-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12891-022-05436-0</ArticleId><ArticleId IdType="pmc">PMC8141233</ArticleId><ArticleId IdType="pubmed">34022863</ArticleId></ArticleIdList></Reference><Reference><Citation>Leon L, Perez-Sancristobal I, Madrid A, Lopez-Pedraza L, Colomer JI, Lerma S, et al. Persistent post-discharge symptoms after COVID-19 in rheumatic and musculoskeletal diseases. Rheumatol Adv Pract. 2022;6:rkac008. doi: 10.1093/rap/rkac008.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/rap/rkac008</ArticleId><ArticleId IdType="pmc">PMC8882379</ArticleId><ArticleId IdType="pubmed">35233480</ArticleId></ArticleIdList></Reference><Reference><Citation>Aikawa NE, Kupa L de VK, Medeiros-Ribeiro AC, Saad CGS, Yuki EFN, Pasoto SG, et al. Increment of immunogenicity after third dose of a homologous inactivated SARS-CoV-2 vaccine in a large population of patients with autoimmune rheumatic diseases. Ann Rheum Dis. 2022;81:1036&#x2013;43. doi: 10.1136/annrheumdis-2021-222096.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/annrheumdis-2021-222096</ArticleId><ArticleId IdType="pubmed">35277389</ArticleId></ArticleIdList></Reference><Reference><Citation>WHO. No Title. Global COVID-19 Clinical Platform Case Report Form (CRF) for Post COVID condition (Post COVID-19 CRF). 2021. p. https://www.who.int/publications/i/item/global-cov.</Citation></Reference><Reference><Citation>NICE. COVID-19 rapid guideline&#x202f;: managing the long-term effects of COVID-19. NICE Guidel. 2020; (18 December 2020).</Citation><ArticleIdList><ArticleId IdType="pubmed">33555768</ArticleId></ArticleIdList></Reference><Reference><Citation>Ayoubkhani D, Bermingham C, Pouwels KB, Glickman M, Nafilyan V, Zaccardi F, et al. Trajectory of long Covid symptoms after COVID-19 vaccination: community-based cohort study. BMJ. 2022;377:e069676. doi: 10.1136/bmj-2021-069676.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj-2021-069676</ArticleId><ArticleId IdType="pmc">PMC9115603</ArticleId><ArticleId IdType="pubmed">35584816</ArticleId></ArticleIdList></Reference><Reference><Citation>See&#xdf;le J, Waterboer T, Hippchen T, Simon J, Kirchner M, Lim A, et al. Clinical infectious diseases persistent symptoms in adult patients 1 year after coronavirus disease 2019 (COVID-19): a prospective cohort study. Clin Infect Dis. 2022;74(7):1191&#x2013;1199. doi: 10.1093/cid/ciab611.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/cid/ciab611</ArticleId><ArticleId IdType="pmc">PMC8394862</ArticleId><ArticleId IdType="pubmed">34223884</ArticleId></ArticleIdList></Reference><Reference><Citation>Overman CL, Kool MB, Da Silva JAP, Geenen R. The prevalence of severe fatigue in rheumatic diseases: an international study. Clin Rheumatol. 2016;35(2):409&#x2013;415. doi: 10.1007/s10067-015-3035-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10067-015-3035-6</ArticleId><ArticleId IdType="pmc">PMC4752960</ArticleId><ArticleId IdType="pubmed">26272057</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>